Phase II Trial of Quality-of-Life Outcomes after Proton Beam for Nasopharyngeal Carcinoma

J. Slater,E.A. Weyman,A.W. Chan

DOI: https://doi.org/10.1016/j.ijrobp.2024.01.125

IF: 8.013

2024-04-01

International Journal of Radiation Oncology*Biology*Physics

Abstract:Purpose/Objective(s) Radiotherapy is a primary treatment modality for nasopharyngeal cancer (NPC). Advances in radiotherapy techniques such as intensity-modulated radiotherapy (IMRT) have shown less detriment in quality of life (QOL). Proton beam therapy (PBT) has potential to further reduce detriment in QOL due to reduced exposure of normal tissues to low-dose radiation. The purpose of this study was to assess patient-reported QOL outcomes after PBT. Materials/Methods Twenty-five patients with biopsy-confirmed stage IIB-IVB nasopharyngeal carcinoma were enrolled on a prospective, phase II, NCI-funded study. The primary endpoint was patient-reported QOL outcomes. Patients were treated with concurrent PBT/cisplatin and adjuvant cisplatin/5-fluorouracil. EORTC-HN35 was performed before PBT and at 1.5, 3, 6, 12, and 24 months following completion of CRT. Wilcoxon signed ranks test were performed to compare difference in means at each time point to baseline. Mann-Whitney test was performed to assess differences in distribution for pooled 12- and 24-month chronic phase data compared to baseline. Results Twenty-three patients had complete baseline and QOL follow-up data at 24 months. The Global Health Status QOL metric at 12 and 24 months was not significantly different from baseline (p=0.39 and p=0.62, respectively). At 12 months the only four domains had a statistically significant decrease from baseline: Head and Neck Pain (baseline mean: 6.5 vs 16.7, p=0.02), Swallowing (mean: 4.3 vs 8.7, p=0.004), Dry Mouth (mean: 18.8 vs 58.3, p=0.001), and Sticky Saliva (mean: 11.6 vs 40.0, p=0.006). At 24 months, the only three domains demonstrated statistically significant decrease from baseline: Swallowing (mean: 4.3 vs 8.3, p=0.033), Dry mouth (mean: 18.8 vs 42.4, p=0.017), and Mouth Opening (mean: 5.8 vs 21.2, p=0.015). For the chronic phase of 12-24 months, Swallowing (p=0.003), Dry mouth (p=0.001), Sticky Saliva (p=0.005), and Mouth Opening (p=0.009) were the only domains different from baseline. In the chronic phase, 43% had responses of “Quite a bit” or “Very Much” to Dry Mouth, 26% to Sticky Saliva, 16% to Mouth Opening, and only 3% to Swallowing. Conclusion This study marks the first study prospectively assessing the QOL outcomes of nasopharyngeal cancer patients treated with PBT. Compared to historical controls, fewer domains were adversely affected at the 12- and 24-month time points. This study demonstrates that with proton beam radiation therapy, the long-term quality of life detriment is minimized. These data provide a foundation for further studies phase III involving proton beam therapy and quality of life.

oncology,radiology, nuclear medicine & medical imaging